Cover Image

Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Chanatip Thanasarnthungcharoen, Supapich Chanasit, Laurence Fievez, Theerayuth Kaewamatawong, Piyachat Patniboon, Paulo J. C. Lin, Fabrice Bureau, Alain Jacquet
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preclinical development of virus‐like particle (VLP)‐based immunotherapy against house dust mite allergy
by: Piyachat Patniboon, et al.
Published: (2024)

Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation
by: Alissa Cait, et al.
Published: (2024)

Reaction severity and peach threshold amount during oral challenge in nonspecific lipid transfer protein allergy
by: Natalia Pérez‐Sánchez, et al.
Published: (2024)

Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
by: Hitasha Rupani, et al.
Published: (2024)

Prevention of allergic airway and gut inflammation in humanized mice by lactobacilli, bifidobacteria, and butyrate
by: Rahul Khatri, et al.
Published: (2024)

Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils
by: Kathleen M. Buchheit, et al.
Published: (2024)

Single‐cell profiling highlight pathogenic myeloid features in house dust mite‐induced murine model of airway inflammation
by: Jiachen Liu, et al.
Published: (2024)

A humanized mouse model to study asthmatic airway remodeling and Muc‐5ac secretion via the human IL‐33
by: Dong Zhang, et al.
Published: (2024)

Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotype
by: Frederikke R. Skov, et al.
Published: (2025)

Improvement of glucocorticoid sensitivity and attenuation of pulmonary allergic reactions by exogenous supplementation with betaine in HDM and LPS‐induced allergic mouse model
by: Qing Wang, et al.
Published: (2025)

Maternal OM‐85 administration alleviates offspring allergic airway inflammation by downregulating IL‐33/ILC2 axis
by: Wei Zou, et al.
Published: (2025)

Evaluation of dupilumab and benralizumab on peripheral airway resistance and reactance
by: Rory Chan, et al.
Published: (2024)

Biologics and airway remodeling in asthma: early, late, and potential preventive effects
by: G. Varricchi, et al.
Published: (2024)

CD8+ T‐cell efficiency is affected by the form of membrane lipids in lipid rafts
by: Artemios Piperakis
Published: (2024)

Comprehensive analysis of resilience of human airway epithelial barrier against short‐term PM2.5 inorganic dust exposure using in vitro microfluidic chip and ex vivo human airway models
by: Ozlem Goksel, et al.
Published: (2024)

Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases
by: Yui Miyabe, et al.
Published: (2024)

Transcriptomic profiles of well‐differentiated airway epithelial cells in response to environmental triggers of asthma exacerbation
by: Antonella Marrocco, et al.
Published: (2024)

Comparison of upper and lower airway expression of SARS‐CoV‐2 receptors in allergic asthma
by: Maral Ranjbar, et al.
Published: (2024)

Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease
by: Kirsten E. Stewart, et al.
Published: (2024)

Allergic inflammation triggers dyslipidemia via IgG signalling
by: Nieves Fernández‐Gallego, et al.
Published: (2024)

Role of IL‐5 in asthma and airway remodelling
by: Rola AbuJabal, et al.
Published: (2024)

Indirect case‐matched comparison of anti‐ IL4Rα versus anti‐ IL5Rα on airway hyperresponsiveness
by: Rory Chan, et al.
Published: (2024)

Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation
by: Yu‐Xin Zheng, et al.
Published: (2024)

Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice
by: Mia Hamilton Jee, et al.
Published: (2024)

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
by: Daniel P. Cook, et al.
Published: (2024)

Neutrophil‐driven and interleukin‐36γ‐associated ocular surface inflammation in chronic Stevens–Johnson syndrome
by: Madhuri Amulya Koduri, et al.
Published: (2024)

Interplay of a well‐known medication and newly discovered transporters driving bacteria‐induced inflammation in psoriasis
by: Greta Lücke
Published: (2024)

Mouse IgE clone SPE‐7 can contain functional mouse IgG
by: Michalina Sypka, et al.
Published: (2024)

Prognostic Value of Combining Serum Tryptase and Bone Mineral Density in Predicting Fractures in Systemic Mastocytosis
by: François Robin, et al.
Published: (2026)

Corrigendum to “Elucidating Allergic Reaction Mechanisms in Response to SARS‐CoV‐2 mRNA Vaccination in Adults”
Published: (2024)

Correction to “Mind and skin: Exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis”
Published: (2024)

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
by: Emma Guttman‐Yassky, et al.
Published: (2024)

Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination
by: Anika M. Valk, et al.
Published: (2024)

Importance of SREBP signaling in controlling lipid metabolism and homeostasis in B cells for future vaccine design
by: Zsófia Unger, et al.
Published: (2024)

Intralymphatic Administration of Naked mRNA Induces Allergen‐Specific IgG , Promotes Th1 Responses and Reduces Anaphylactic Potential
by: Marta Paolucci, et al.
Published: (2025)

Integrated gut metabolome and microbiome fingerprinting reveals that dysbiosis precedes allergic inflammation in IgE‐mediated pediatric cow's milk allergy
by: Ellen De Paepe, et al.
Published: (2024)

Mast cell responses in a mouse model of food allergy are regulated via a ST2/IL‐4 axis
by: Saurav Ranjitkar, et al.
Published: (2024)

SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
by: Lik Hang Lam, et al.
Published: (2024)

Type 2 gene expression signature in severe asthma associates with more advanced airway remodeling
by: Bogdan Jakiela, et al.
Published: (2025)

Evaluation of real‐world efficacy of mepolizumab on SNOT‐22 outcomes in patients with unified airway disease
by: Ruperto González‐Pérez, et al.
Published: (2024)